Opportunity Information: Apply for PAR 13 149
Apply for PAR 13 149
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIAID Clinical Trial Implementation Grant (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855 Allergy and Infectious Diseases Research 93.856 Microbiology and Infectious Diseases Research.
- This funding opportunity was created on Mar 22, 2013 and posted on Mar 22, 2013.
- Applicants must submit their applications by Jan 13, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Native American tribal governments (Federally recognized) County governments Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Special district governments Public housing authorities/Indian housing authorities For profit organizations other than small businesses Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Private institutions of higher education Small businesses.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIAID Clinical Trial Implementation Grant (R01) is a discretionary NIH funding opportunity (FOA number PAR-13-149) from the National Institute of Allergy and Infectious Diseases that supports the implementation of investigator-initiated clinical trials that are not considered high risk. The central aim is to fund hypothesis-driven trials that fit squarely within NIAID's scientific mission in allergy, immunology, and infectious diseases, and that NIAID views as high priority. Applicants are specifically encouraged to align proposed work with NIAID's stated planning priorities and research areas, referenced on the institute's website, because the trial topic must not only be mission-relevant but also positioned as important to the institute's current programmatic needs.
This opportunity uses the NIH R01 research project grant mechanism, but it is explicitly tailored to clinical trial implementation rather than early exploratory work. In practical terms, it is meant for carrying out a defined clinical trial protocol rather than proposing multiple trials or a broad clinical research program. A key structural restriction is that only one clinical trial may be included per application, which signals that the application is expected to be focused and fully developed around a single, clearly justified study with an implementable design.
The funding instrument type is a grant, and the activity category is health. The opportunity is associated with CFDA numbers 93.855 (Allergy and Infectious Diseases Research) and 93.856 (Microbiology and Infectious Diseases Research. There is no cost-sharing or matching requirement, meaning applicants are not required to provide non-federal matching funds as a condition of award.
Eligibility is broad and includes many types of domestic applicants such as public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status, with the usual NIH distinctions), for-profit organizations (other than small businesses and also including small businesses), and a wide range of government entities (state, county, city or township, special district governments, independent school districts, and public housing authorities/Indian housing authorities). The FOA also recognizes a variety of mission-relevant institutions and community-based entities as eligible, including faith-based or community-based organizations and several categories of minority-serving institutions such as HBCUs, Hispanic-serving institutions, Tribally Controlled Colleges and Universities, Alaska Native and Native Hawaiian Serving Institutions, and AANAPISIs. In addition, the announcement allows non-U.S. participation: non-domestic (non-U.S.) entities and foreign institutions are eligible to apply, non-domestic components of U.S. organizations are eligible, and foreign components (as defined under NIH policy) are allowed, which can be important for infectious disease trials that may require international sites or populations.
The announcement was posted and created on March 22, 2013. The original and current closing date listed is January 13, 2016, and the archive date is February 13, 2016, indicating that this particular FOA is no longer active for new submissions under those dates and has been moved to the NIH archived listings. Applicants looking for a current equivalent would typically need to search NIH's active FOAs for the most recent NIAID clinical trial implementation R01 announcement and confirm current requirements, clinical trial definitions, and submission policies.
For reference and full details, the FOA points to the NIH Grants Guide page (the Additional Information link) and provides contacts for technical access issues through the NIH Office of Extramural Research webmaster email addresses.
Frequently Asked Questions (FAQs)
What is the NIAID Clinical Trial Implementation Grant (R01)?
The NIAID Clinical Trial Implementation Grant (R01) is an NIH discretionary funding opportunity from the National Institute of Allergy and Infectious Diseases (NIAID) that supports the implementation of investigator-initiated clinical trials that are not considered high risk. The funding opportunity announcement (FOA) number provided is PAR-13-149, and it uses the NIH R01 research project grant mechanism, tailored specifically for clinical trial implementation.
What kind of clinical trials does this FOA support?
This FOA supports hypothesis-driven clinical trials that fit within NIAID's scientific mission in allergy, immunology, and infectious diseases. It is intended for implementing a defined clinical trial protocol rather than proposing multiple trials or a broad clinical research program, and it focuses on trials that NIAID views as high priority and not high risk.
What is the main purpose or central aim of this opportunity?
The central aim is to fund hypothesis-driven clinical trials that are mission-relevant to NIAID and aligned with NIAID's priorities. The FOA emphasizes that the trial topic must both fit NIAID's mission areas (allergy, immunology, and infectious diseases) and be positioned as important to NIAID's current programmatic needs.
How important is alignment with NIAID planning priorities and research areas?
Alignment is specifically encouraged. Applicants are encouraged to align proposed work with NIAID's stated planning priorities and research areas referenced on the institute's website, because the trial topic must be mission-relevant and also reflect what NIAID considers high priority at the time.
Is this FOA meant for early exploratory studies or for implementing a finished trial protocol?
It is explicitly tailored to clinical trial implementation rather than early exploratory work. In practical terms, it is meant for carrying out a defined clinical trial protocol.
Can an application propose more than one clinical trial?
No. A key restriction is that only one clinical trial may be included per application, indicating that the application is expected to be focused on a single, clearly justified study with an implementable design.
What is the funding mechanism and type?
The opportunity uses the NIH R01 research project grant mechanism. The funding instrument type is a grant, and the activity category is health.
What CFDA numbers are associated with this opportunity?
The opportunity is associated with CFDA 93.855 (Allergy and Infectious Diseases Research) and CFDA 93.856 (Microbiology and Infectious Diseases Research).
Is cost-sharing or matching required?
No. There is no cost-sharing or matching requirement, meaning applicants are not required to provide non-federal matching funds as a condition of award.
Who is eligible to apply?
Eligibility is broad and includes many types of applicants such as public and private institutions of higher education; nonprofit organizations (including those with and without 501(c)(3) status, consistent with NIH distinctions); for-profit organizations (including small businesses and other than small businesses); and a wide range of government entities (state, county, city or township, special district governments, independent school districts, and public housing authorities/Indian housing authorities).
Are community-based and faith-based organizations eligible?
Yes. The FOA recognizes faith-based or community-based organizations as eligible applicants.
Are minority-serving institutions eligible to apply?
Yes. Several categories of minority-serving institutions are identified as eligible, including HBCUs, Hispanic-serving institutions, Tribally Controlled Colleges and Universities, Alaska Native and Native Hawaiian Serving Institutions, and AANAPISIs.
Are foreign (non-U.S.) organizations allowed to apply?
Yes. The announcement allows non-U.S. participation, including eligibility for non-domestic (non-U.S.) entities and foreign institutions to apply.
Can U.S. organizations include non-U.S. components?
Yes. Non-domestic components of U.S. organizations are eligible, and foreign components (as defined under NIH policy) are allowed. This can be relevant for infectious disease trials that may require international sites or populations.
When was this FOA posted?
The announcement was posted and created on March 22, 2013.
What were the closing date and archive date for this FOA?
The original and current closing date listed is January 13, 2016, and the archive date is February 13, 2016.
Is this FOA currently active for new submissions?
Based on the listed closing and archive dates, this particular FOA is no longer active for new submissions under those dates and has been moved to the NIH archived listings.
If this FOA is archived, what should applicants do to find a current equivalent?
Applicants would typically need to search NIH's active FOAs for the most recent NIAID clinical trial implementation R01 announcement and confirm current requirements, clinical trial definitions, and submission policies.
Where can applicants find the full official details for this opportunity?
The FOA points to the NIH Grants Guide page via the Additional Information link for reference and full details.
Who should be contacted for technical access issues related to the FOA information?
The FOA provides contacts for technical access issues through NIH Office of Extramural Research webmaster email addresses.
Browse more opportunities from the same category: Health
Next opportunity: NIAID Clinical Trial Planning Grant (R34)
Previous opportunity: ROSES 2013 Origins of Solar Systems
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 13 149
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 13 149) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIAID Clinical Trial Planning Grant (R34) Apply for PAR 13 150 Funding Number: PAR 13 150 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01) Apply for PAR 13 151 Funding Number: PAR 13 151 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Aging Research Dissertation Awards to Increase Diversity (R36) Apply for PAR 13 152 Funding Number: PAR 13 152 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development and Characterization of Animal Models for Aging Research (R01) Apply for PA 13 155 Funding Number: PA 13 155 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development and Characterization of Animal Models for Aging Research (R21) Apply for PA 13 156 Funding Number: PA 13 156 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Using Evidence from Science and Community Practice to Develop Web and other Technology Based Tools for HIV Treatment Service Provider Organizations to Improve Linkage, Retention, and Re Engagement of HIV Positive Persons in Care Apply for CDC RFA PS13 1311 Funding Number: CDC RFA PS13 1311 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Drug Target Development and Validation for Antimicrobial Resistant Pathogens (R21/R33) Apply for RFA AI 13 019 Funding Number: RFA AI 13 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01) Apply for RFA AA 13 003 Funding Number: RFA AA 13 003 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R21) Apply for RFA AA 13 004 Funding Number: RFA AA 13 004 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Functional Characterization of Oral Cancer Initiating Cells (R01) Apply for RFA DE 14 001 Funding Number: RFA DE 14 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Functional Characterization of Oral Cancer Initiating Cells (R21) Apply for RFA DE 14 002 Funding Number: RFA DE 14 002 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| KNOWLEDGE FOR HEALTH II Apply for SOL OAA 13 000048 Funding Number: SOL OAA 13 000048 Agency: Agency for International Development Category: Health Funding Amount: $40,000,000 |
| Using Traditional Foods and Sustainable Ecological Approaches for Health Promotion and Diabetes Prevention in American Indian/Alaska Native (AI/AN) Communities CC RFA DP08 819 Apply for CDC RFA DP13 1317 Funding Number: CDC RFA DP13 1317 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Delta Health Care Services Program Apply for RBS01 2012 DHCS Funding Number: RBS01 2012 DHCS Agency: Business and Cooperative Programs Category: Health Funding Amount: Case Dependent |
| Alcohol Use Disorders Treatment, Services, and Recovery Research (R01) Apply for PA 13 160 Funding Number: PA 13 160 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Use Disorders Treatment, Services, and Recovery Research (R21) Apply for PA 13 161 Funding Number: PA 13 161 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Alcohol Use Disorders Treatment, Services, and Recovery Research (R03) Apply for PA 13 162 Funding Number: PA 13 162 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Program to Support New Implementation of State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening of Severe Combined Immunodeficiency (SCID) Apply for CDC RFA EH13 1303 Funding Number: CDC RFA EH13 1303 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Strategic Prevention Framework Partnerships for Success (SPF PFS) Apply for SP 13 004 Funding Number: SP 13 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $2,260,000 |
| Secondary Analyses of Existing Data Sets and Stored Biospecimens to Address Clinical Aging Research Questions (R01) Apply for PA 13 168 Funding Number: PA 13 168 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 149", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.